Valiant Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories Limited has submitted its quarterly financial results to the NSE for the period ended December 31, 2025 (Q3 FY25-26). This is a standard regulatory filing announcing the submission of results, typically covering standalone and/or consolidated revenue, expenses, and profit figures for the quarter and nine months ended December 2025. The actual detailed numbers, segment performance, and audit observations would be available in the attached financial result document. Investors should review the full results PDF for line-item details.
No immediate price impact from the filing itself — this is a procedural disclosure confirming that results have been filed. The actual numbers within the submitted document will determine market reaction once analysed.